B3GNT6 suppresses colorectal cancer progression by inhibiting the KRAS/ERK signaling pathway
{{output}}
Background: Colorectal cancer (CRC) is one of the most common malignancies with high morbidity and mortality worldwide. B3GNT6 as been predicted to serve as a prognostic indicator for CRC patients, but its biological function and... ...
